5-Amino-2-hydroxy-nicotinic acid methyl ester
![]() |
- $311 - $1050
- Product name: 5-Amino-2-hydroxy-nicotinic acid methyl ester
- CAS: 89694-08-6
- MF: C7H8N2O3
- MW: 168.15
- EINECS:
- MDL Number:MFCD20705222
- Synonyms:5-Amino-2-hydroxy-nicotinic acid methyl ester;Methyl 5-amino-2-oxo-1,2-dihydropyridine-3-carboxylate;3-Pyridinecarboxylic acid, 5-amino-1,2-dihydro-2-oxo-, methyl ester;methyl 5-amino-2-hydroxynicotinate
4 prices
Selected condition:
Brand
- Chemcia Scientific
- Chemenu
- Crysdot
- TRC
Package
- 1g
- 5G
- ManufacturerChemcia Scientific
- Product numberBB20-3371B
- Product description5-Amino-2-hydroxy-nicotinicacidmethylester 95%
- Packaging5G
- Price$1050
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM319940
- Product descriptionMethyl5-amino-2-hydroxypyridine-3-carboxylate 95%
- Packaging1g
- Price$311
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11025450
- Product descriptionMethyl5-amino-2-hydroxypyridine-3-carboxylate 95+%
- Packaging1g
- Price$330
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM328348
- Product descriptionMethyl5-amino-2-hydroxypyridine-3-carboxylate
- Packaging1g
- Price$965
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Chemcia Scientific | BB20-3371B | 5-Amino-2-hydroxy-nicotinicacidmethylester 95% | 5G | $1050 | 2021-12-16 | Buy |
Chemenu | CM319940 | Methyl5-amino-2-hydroxypyridine-3-carboxylate 95% | 1g | $311 | 2021-12-16 | Buy |
Crysdot | CD11025450 | Methyl5-amino-2-hydroxypyridine-3-carboxylate 95+% | 1g | $330 | 2021-12-16 | Buy |
TRC | M328348 | Methyl5-amino-2-hydroxypyridine-3-carboxylate | 1g | $965 | 2021-12-16 | Buy |
Properties
Boiling point :342.6±42.0 °C(Predicted)
Density :1.326±0.06 g/cm3(Predicted)
pka :10.91±0.10(Predicted)
Density :1.326±0.06 g/cm3(Predicted)
pka :10.91±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|